Trial Profile
A phase I open-label, randomised, 3-way crossover drug-interaction study of co-administration of OBE001 and betamethasone in healthy non-pregnant women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Feb 2016
Price :
$35
*
At a glance
- Drugs Nolasiban (Primary) ; Betamethasone
- Indications Preterm labour
- Focus Adverse reactions; Pharmacokinetics
- 02 Mar 2015 New trial record
- 26 Feb 2015 Status changed from active, no longer recruiting to completed according to an ObsEva media release.
- 26 Feb 2015 Results published in an ObsEva media release.